KISQALI is a targeted treatment for HR+ (ER+ and/or PR+), HER2- metastatic breast cancer that blocks, or interferes with, substances that play a key role in cancer cell growth and survival. KISQALI affects cancer cells, but can also affect healthy cells.
People also ask
What type of cancer does Kisqali treat?
Do you take kisqali forever?
How much does kisqali extend life?
What are the benefits of Kisqali?
Kisqali (ribociclib) is a CDK4/6 inhibitor used to treat certain cases of estrogen-receptor-positive, HER2-negative breast cancer.
Jan 11, 2023 · Ribociclib has become a commonly used treatment for ER-positive, HER2-negative breast cancer that requires treatment beyond surgery and ...
5 days ago · Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes Kisqali side effects, interactions and ...
Learn about KISQALI, a treatment option for HER+, HER2- early breast cancer (eBC) and metastatic breast cancer (mBC). See full Prescribing and Safety Info.
Sep 13, 2023 · Kisqali (ribociclib) is a prescription drug that's used to treat breast cancer. Kisqali comes as a tablet that you swallow.
Aug 26, 2024 · Kisqali (ribociclib) is commonly used for treating breast cancer that is hormone receptor (HR)-positive and human epidermal growth factor ...
Kisqali is a brand-name prescription medication. It's used to treat a form of advanced breast cancer in women. Kisqali treats breast cancer that is: metastatic ...
KISQALI + hormone therapy work to stop your cancer from growing and spreading. KISQALI is taken with a hormone therapy. Hormone therapy is a type of medication ...
Ribociclib is a targeted or biological therapy drug. When used to treat breast cancer, ribociclib is taken alongside hormone (endocrine) therapy.
